Standard pharmacological treatment for gout attacks includes colchicine, NSAIDs, and the option of oral or intramuscular corticosteroids, with IL-1 inhibitors newly identified as an option for refractory attacks resistant to standard therapy (Yuan et al., 2025). The gene discussed is IL1B; the disease is gout.